Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 19, 2021
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neos Therapeutics, Inc.
| -446.82K |
—
|
—
| -100.00% |
0
|
Mar 19
| |||||||
Neos Therapeutics, Inc.
| 23.45K |
—
|
—
| +5.54% | 446.82K |
Jun 10
| |||||||
Neos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Neos Therapeutics, Inc.
| 43.48K |
$2.30 | $99,999.40 | +11.44% | 423.37K |
Nov 8
| |||||||
Neos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 2
| |||||||
Neos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 3
| |||||||
Neos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Neos Therapeutics, Inc.
| 10K |
$7.61 | $76,100.00 | +2.70% | 379.89K |
May 19
| |||||||
Neos Therapeutics, Inc.
| 259.74K |
$1.44 |
—
| +235.80% | 369.89K |
Jul 27 - Jul 28
| |||||||
Neos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 22
| |||||||
Neos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Savient Pharmaceuticals Inc
| 7.5K |
$3.99 | $29,925.00 | +22.95% | 40.18K |
Sep 15
| |||||||
Savient Pharmaceuticals Inc
| 5.29K |
$7.78 | $41,163.98 | +19.32% | 32.68K |
May 26
| |||||||
Savient Pharmaceuticals Inc
| 3.51K |
—
|
—
| +14.72% | 27.39K |
Jun 8
| |||||||
Savient Pharmaceuticals Inc
| 3.51K |
$11.38 | $39,989.32 | +14.72% | 27.39K |
Jun 8
| |||||||
Savient Pharmaceuticals Inc
| 7.45K |
$5.37 | $39,995.76 | +45.34% | 23.87K |
May 5
| |||||||
Applied Neurosolutions Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 24
| |||||||
Northfield Laboratories Inc /de/
| 13.04K |
—
|
—
| +132.56% | 22.88K |
Jan 2
| |||||||
Applied Neurosolutions Inc
| 40K |
$0.07 | $2,800.00 | +32.00% | 165K |
Sep 10
| |||||||
Applied Neurosolutions Inc
| 25K |
$0.08 | $1,875.00 | +25.00% | 125K |
Sep 9
| |||||||
Savient Pharmaceuticals Inc
| 1.62K |
$24.66 | $39,998.52 | +10.96% | 16.43K |
May 13
| |||||||
Applied Neurosolutions Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 7
| |||||||
Applied Neurosolutions Inc
| 50K |
$0.14 | $7,000.00 | +100.00% | 100K |
Dec 17
| |||||||
Applied Neurosolutions Inc
| 50K |
$0.15 | $7,500.00 |
∞
| 50K |
Nov 16
| |||||||
Northfield Laboratories Inc /de/
| 7.28K |
$2.06 | $15,000.92 | +284.68% | 9.84K |
Sep 25
| |||||||
Savient Pharmaceuticals Inc
| 3.28K |
$12.77 | $41,847.29 | +28.43% | 14.8K |
May 15
| |||||||
Savient Pharmaceuticals Inc
| 311 |
$12.02 | $3,738.22 | +2.77% | 11.53K |
Mar 30
| |||||||
Savient Pharmaceuticals Inc
| 334 |
$11.21 | $3,744.14 | +3.07% | 11.22K |
Dec 29
| |||||||
Savient Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 29
| |||||||
Savient Pharmaceuticals Inc
| 576 |
$6.51 | $3,749.76 | +5.59% | 10.88K |
Sep 29
| |||||||
Northfield Laboratories Inc /de/
| 1.15K |
—
|
—
| +81.93% | 2.56K |
Sep 20
| |||||||
Applied Neurosolutions Inc
|
0
|
—
|
—
|
—
|
0
|
Sep 7
| |||||||
Applied Neurosolutions Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Savient Pharmaceuticals Inc
| 306 |
$5.25 | $1,606.50 | +3.06% | 10.31K |
Jun 30
| |||||||
Savient Pharmaceuticals Inc
| 306 |
$5.25 | $1,606.50 | +3.06% | 10.31K |
Jun 30
| |||||||
Savient Pharmaceuticals Inc
| 10K |
$5.49 | $54,917.00 |
∞
| 10K |
May 25
| |||||||
Savient Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Northfield Laboratories Inc /de/
| 1.41K |
$10.67 | $15,002.02 |
∞
| 1.41K |
Feb 24
| |||||||
Northfield Laboratories Inc /de/
|
0
|
—
|
—
|
—
|
0
| ||||||||
Northfield Laboratories Inc /de/
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.